Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen (Q43602370)

25 November 2017

title

Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen (English)

1 reference

25 November 2017

0 references

1 reference

Park HS

1

1 reference

25 November 2017

Nahm DH

2

1 reference

25 November 2017

Kim HY

3

1 reference

25 November 2017

Suh YJ

4

1 reference

25 November 2017

Cho JW

5

1 reference

25 November 2017

Kim SS

6

1 reference

25 November 2017

Lee SK

7

1 reference

25 November 2017

Jung KS

8

1 reference

25 November 2017

publication date

1 April 2001

1 reference

Annals of Allergy, Asthma & Immunology

25 November 2017

published in

1 reference

25 November 2017

volume

86

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

444-448

1 reference

Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Position paper: Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Evidence of Hop Japanese pollinosis in Korea: IgE sensitization and identification of allergenic components

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Efficacy of specific immunotherapy in allergic asthma: myth or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Mechanisms of specific immunotherapy of allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Allergen-specific treatment for asthma: III

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Allergen-specific immunotherapy. Present state and directions for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Serum Levels of Specific IgE, Soluble Interleukin-2 Receptor, and Soluble Intercellular Adhesion Molecule-1 in Seasonal Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immu

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Soluble cytokine receptor CD30 in atopic disorders: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

Restoration of cytokine imbalance by immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962493-3

7 January 2021

10.1016/S1081-1206(10)62493-3

Identifiers

DOI

1 reference

25 November 2017

1 reference